Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SPARC anticorps

SPARC Reactivité: Humain WB, IHC, ELISA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN307028
  • Antigène Voir toutes SPARC Anticorps
    SPARC (Secreted Protein, Acidic, Cysteine-Rich (Osteonectin) (SPARC))
    Reactivité
    • 84
    • 44
    • 39
    • 11
    • 6
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 79
    • 20
    • 4
    • 2
    • 2
    Lapin
    Clonalité
    • 83
    • 24
    Polyclonal
    Conjugué
    • 63
    • 14
    • 8
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp SPARC est non-conjugé
    Application
    • 91
    • 44
    • 34
    • 22
    • 13
    • 13
    • 10
    • 10
    • 10
    • 10
    • 8
    • 5
    • 5
    • 5
    • 5
    • 3
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
     Réactivité croisée
    Humain
    Attributs du produit
    Secreted Protein Acidic and Rich in Cysteine, SPARC, SPARC-related modular calcium-binding protein 2 [Precursor], Secreted modular calcium-binding protein 2, SMOC-2, Smooth muscle-associated protein 2, SMAP-2,SPARC is a key factor in cell-matrix interactions and possibly tumour aggressiveness. The SPARC gene, which encodes a multifunctional glycoprotein with roles in tissue development, remodelling and fibrosis. A regulator of cell-extracellular matrix (ECM) interactions, SPARC represents a major factor in the ECM remodelling occurring during tumour invasion. in silico analysis reveals 4 UTR-SNPs located in the 3 -UTR of the SPARC gene, corresponding to 1474 g a, 1551 g c, 1922 t g and 2072 c t changes, which are significantly associated with tumoral state of the tissue. Of all hits, the 2072 SPARC polymorphism had the best association with cancer. SPARC therefore is a gene involved in a number of diseases including rheumatoid arthritis, scleroderma, tumor development and metastasis. SPARC variants have been detected in tumour samples of patients with acute myeloblastic leukemia (AML).
    Purification
    Ammonium Sulfate Precipitation
    Immunogène
    Rabbit immunized with a synthetic peptide derived from the human SPARC protein.
    Isotype
    IgG
    Top Product
    Discover our top product SPARC Anticorps primaire
  • Indications d'application
    Antibody can be used for Western blotting (1-5 μg/mL), Immunohistochemistry and ELISA. Optimal concentration should be evaluated by serial dilutions.
    Restrictions
    For Research Use only
  • Buffer
    Provided as solution in phosphate buffered saline with 0.08 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
  • Antigène
    SPARC (Secreted Protein, Acidic, Cysteine-Rich (Osteonectin) (SPARC))
    Autre désignation
    SPARC (SPARC Produits)
    Synonymes
    anticorps ON, anticorps AA517111, anticorps BM-40, anticorps hm:zeh0062, anticorps SPARC, anticorps sparc, anticorps secreted protein acidic and cysteine rich, anticorps secreted acidic cysteine rich glycoprotein, anticorps secreted protein, acidic, cysteine-rich (osteonectin), anticorps secreted protein, acidic, cysteine-rich (osteonectin) L homeolog, anticorps secreted protein, acidic, cysteine-rich (osteonectin) S homeolog, anticorps SPARC, anticorps Sparc, anticorps sparc, anticorps sparc.L, anticorps sparc.S
    UniProt
    P09486
    Pathways
    Autophagy
Vous êtes ici:
Support technique